4//SEC Filing
Maduck Sean 4
Accession 0001193125-25-267542
CIK 0001088856other
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 7:56 PM ET
Size
12.2 KB
Accession
0001193125-25-267542
Insider Transaction Report
Form 4
Maduck Sean
See Remarks
Transactions
- Sale
Common Stock
2025-11-03$73.99/sh−20,000$1,479,816→ 7,904 total - Exercise/Conversion
Common Stock
2025-11-03$8.27/sh+20,000$165,400→ 27,904 total - Exercise/Conversion
Stock option (right to buy)
2025-11-03−20,000→ 261,986 totalExercise: $8.27Exp: 2027-02-10→ Common Stock (20,000 underlying)
Holdings
- 40,000(indirect: See Footnote)
Common Stock
- 10,000(indirect: See Footnote)
Common Stock
- 59,717(indirect: See Footnote)
Common Stock
Footnotes (7)
- [F1]Includes 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 228 underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
- [F2]This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on September 5, 2024 in effect at the time of this transaction.
- [F3]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $73.47 to $74.27 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F4]Represents the shares held by Sean and Molly Maduck Living Trust of which the Reporting Person is a co-trustee.
- [F5]Represents the shares held by SNM 2025 Grantor Retained Annuity Trust of which the Reporting Person is the trustee.
- [F6]Represents the shares held by Duckhill Capital, LLC of which the Reporting Person is President and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
- [F7]Fully exercisable.
Documents
Issuer
CORCEPT THERAPEUTICS INC
CIK 0001088856
Entity typeother
Related Parties
1- filerCIK 0001698310
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 7:56 PM ET
- Size
- 12.2 KB